Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
76-90 of 390
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Project Oncology®Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
The Next Chapter: SABCS 2025 and the Future of HR+ HER2− Breast Cancer Care
Project Oncology®The Next Chapter: SABCS 2025 and the Future of HR+ HER2− Breast Cancer Care
Pavani Chalasani, MD, MPH
Alison Stopeck, MD
Genomic Profile of ER+ HER2- Metastatic Invasive Lobular Carcinoma
Project Oncology®Genomic Profile of ER+ HER2- Metastatic Invasive Lobular Carcinoma
Pavani Chalasani, MD, MPH
Kristina Fanucci, MD, MHS
Evaluating Post-CDK4/6 Therapy in PIK3CA-Mutated Metastatic Breast Cancer
Project Oncology®Evaluating Post-CDK4/6 Therapy in PIK3CA-Mutated Metastatic Breast Cancer
Jennifer Caudle, DO, FACOFP
Maxwell Llyod, MD
The Metabolic Roots of Early-Onset Colorectal Cancer
Project Oncology®The Metabolic Roots of Early-Onset Colorectal Cancer
Exercise in CRC Survivors: A Closer Look at Biomarker Effects
Project Oncology®Exercise in CRC Survivors: A Closer Look at Biomarker Effects
- advertisement
AI-Assisted Colonoscopy Improves Polyp Detection and Diagnostic Accuracy
Project Oncology®AI-Assisted Colonoscopy Improves Polyp Detection and Diagnostic Accuracy
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Project Oncology®Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Alexandria May, PharmD, BCPS
Nicholas Whipple, MD, MPH
Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer
Project Oncology®Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer
Pavani Chalasani, MD, MPH
Timothy Yap, MBBS, PhD, FRCP
From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
Project Oncology®From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
Seth Wander, MD, PhD
Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Project Oncology®Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Ryan Quigley
Kathrin M. Bernt, MD
Rushabh Mehta, BS
Fatemeh Alikarami
Giredestrant and Everolimus in HR+/HER2- Breast Cancer: Insights from evERA
Project Oncology®Giredestrant and Everolimus in HR+/HER2- Breast Cancer: Insights from evERA
Pavani Chalasani, MD, MPH
Erica L. Mayer, MD, MPH
- advertisement
SERENA-6: Assessing Camizestrant’s Impact in HR+/HER2- Breast Cancer
Project Oncology®SERENA-6: Assessing Camizestrant’s Impact in HR+/HER2- Breast Cancer
Pavani Chalasani, MD, MPH
Erica L. Mayer, MD, MPH
Growth Recovery After Tovorafenib in Pediatric Low-Grade Gliomas: New Data
Project Oncology®Growth Recovery After Tovorafenib in Pediatric Low-Grade Gliomas: New Data
Alexandria May, PharmD, BCPS
Daniel Landi, MD
Advancing Endometrial Cancer Care: Molecular Targets and Emerging Therapies
Project Oncology®Advancing Endometrial Cancer Care: Molecular Targets and Emerging Therapies
Casey Cosgrove, MD
